Humanized antibody-cytokine fusion protein demonstrates immunological activity in phase I trial May 26, 1999 No Comments
MDX-447 shows promising biological activity in phase I/II trial, results reported at ASCO meeting May 25, 1999 No Comments
News from ASCO: phase I trial of PNU-214565 dose escalation tied to baseline anti-SEA antibodies May 21, 1999 No Comments
Avax enters research agreement with University of Tokyo for breast cancer vaccine May 21, 1999 No Comments
Ligand confirms that ECOG has initiated multicenter phase II study of Ontak for NHL May 13, 1999 No Comments
Promising phase I/II results for Leuvectin in prostate cancer presented at AUA meeting May 5, 1999 No Comments
Cantab in-licenses Novasomes adjuvant for use in TA-CIN vaccine; clinical testing in sight April 26, 1999 No Comments
RSS